External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients
- PMID: 34553428
- DOI: 10.1111/iju.14701
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients
Abstract
Objectives: To test the effect of race/ethnicity on cancer-specific mortality after radical prostatectomy or external beam radiotherapy in localized prostate cancer patients.
Methods: In the Surveillance, Epidemiology and End Results database 2004-2016, we identified intermediate-risk and high-risk white (n = 151 632), Asian (n = 11 189), Hispanic/Latino (n = 20 077) and African American (n = 32 550) localized prostate cancer patients, treated with external beam radiotherapy or radical prostatectomy. Race/ethnicity-stratified cancer-specific mortality analyses relied on competing risks regression, after propensity score matching for patient and cancer characteristics.
Results: Compared with white patients, Asian intermediate- and high-risk external beam radiotherapy patients showed lower cancer-specific mortality (hazard ratio 0.58 and 0.70, respectively, both P ≤ 0.02). Additionally, Asian high-risk radical prostatectomy patients also showed lower cancer-specific mortality than white patients (hazard ratio 0.72, P = 0.04), but not Asian intermediate-risk radical prostatectomy patients (P = 0.08). Conversely, compared with white patients, African American intermediate-risk radical prostatectomy patients showed higher cancer-specific mortality (hazard ratio 1.36, P = 0.01), but not African American high-risk radical prostatectomy or intermediate- and high-risk external beam radiotherapy patients (all P ≥ 0.2). Finally, compared with white people, no cancer-specific mortality differences were recorded for Hispanic/Latino patients after external beam radiotherapy or radical prostatectomy, in both risk levels (P ≥ 0.2).
Conclusions: Relative to white patients, an important cancer-specific mortality advantage applies to intermediate-risk and high-risk Asian prostate cancer patients treated with external beam radiotherapy, and to high-risk Asian patients treated with radical prostatectomy. These observations should be considered in pretreatment risk stratification and decision-making.
Keywords: Epidemiology and End Results; Surveillance; cancer-specific mortality; external beam radiotherapy; localized prostate cancer; other-cause mortality; radical prostatectomy.
© 2021 The Authors. International Journal of Urology published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.
Comment in
-
Editorial Comment to External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients.Int J Urol. 2022 Jan;29(1):24-25. doi: 10.1111/iju.14723. Epub 2021 Oct 4. Int J Urol. 2022. PMID: 34608681 No abstract available.
-
Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients.Int J Urol. 2022 Jan;29(1):95. doi: 10.1111/iju.14741. Epub 2021 Nov 5. Int J Urol. 2022. PMID: 34739157 No abstract available.
References
-
- Mahal BA, Berman RA, Taplin M-E et al. Prostate cancer-specific mortality across Gleason Scores in Black vs Nonblack Men. JAMA 2018; 320: 2479.
-
- Steele CB, Li J, Huang B et al. Prostate cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer 2017; 123: 5160-77.
-
- Gray PJ, Lin CC, Cooperberg MR et al. Temporal trends and the impact of race, insurance, and socioeconomic status in the management of localized prostate cancer. Eur. Urol. 2017; 71: 729-37.
-
- Man A, Pickles T, Chi KN. Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer. J. Urol. 2003; 170: 901-4.
-
- Chinea FM, Patel VN, Kwon D et al. Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study. Oncotarget 2017; 8: 69709-21.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
